Evidence map›Paper›PMID 29568440›Full record

ArticleChemical science2017

Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists.

Xing Zhang, Vijayakanth Pagadala, Hannah M Jester, Andrew M Lim, Truong Quang Pham, Anna Marie P Goulas, Jian Liu, Robert J Linhardt

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Review
  3. Synthetic biology for heparin biomanufacturing.Bioresources and bioprocessing · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Non-anticoagulant heparin derivatives for COVID-19 treatment.International journal of biological macromolecules · 2023
    Review
  13. Review
  14. NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Emerging chemical and biochemical tools for studying 3-American journal of physiology. Cell physiology · 2022
    Review
  20. Analysis of 3-Analytical chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xing ZhangDepartment of Chemistry and Chemical Biology , Rensselaer Polytechnic Institute , Troy , New York 12180 , USA . Email: linhar@rpi.edu.
Vijayakanth PagadalaGlycan Therapeutics , LLC , Chapel Hill , North Carolina 27599 , USA.ORCID 0000-0001-7349-4230
Hannah M JesterGlycan Therapeutics , LLC , Chapel Hill , North Carolina 27599 , USA.
Andrew M LimGlycan Therapeutics , LLC , Chapel Hill , North Carolina 27599 , USA.
Truong Quang PhamDivision of Chemical Biology and Medicinal Chemistry , Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , USA . Email: liuj@email.unc.edu.
Anna Marie P GoulasGlycan Therapeutics , LLC , Chapel Hill , North Carolina 27599 , USA.
Jian LiuDivision of Chemical Biology and Medicinal Chemistry , Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , USA . Email: liuj@email.unc.edu.
Robert J LinhardtDepartment of Chemistry and Chemical Biology , Rensselaer Polytechnic Institute , Troy , New York 12180 , USA . Email: linhar@rpi.edu.ORCID 0000-0003-2219-5833
Communities In Schools of Orange County · USRensselaer Polytechnic Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

In vitro synthesis of recombinant heparan sulfateR01HL094463 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JIAN, PAWLINSKI, RAFAL L · 2009 to 2021
$5.2M
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined DrugsR01HL062244 · NHLBI · UNIVERSITY OF IOWA · PI DEANGELIS, PAUL L, LINHARDT, ROBERT J · 2001 to 2016
$4.1M
Uncovering the controlling mechanisms in heparan sulfate biosynthesisU01GM102137 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JIAN · 2013 to 2016
$1.2M
NCI NIH HHS HHSN261201500019CNHLBI NIH HHS R01 HL062244NHLBI NIH HHS R01 HL094463NIGMS NIH HHS U01 GM102137
6 · The paper itself

Abstract

Heparan sulfate (HS) is a member of the glycosaminoglycans (GAG) family that plays essential roles in biological processes from animal sources. Heparin, a highly sulfated form of HS, is widely used as anticoagulant drug worldwide. The high diversity and complexity of HS and heparin represent a roadblock for structural characterization and biological activity studies. Access to structurally defined oligosaccharides is critical for the successful development of HS and heparin structure-activity relationships. In this study, a library of

Identifiers

PMID29568440
PMCPMC5849142
OpenAlexW2759085391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.